Is reporting of trial data for Phase I in Oncology trials required or does that apply only to phase 1 normal healthy volunteer studies?

At this time, results of Phase I trials are not required to be reported per FDAAA regardless of whether conducted in patients or healthy volunteers. Phase I trials conducted in patients with serious/life-threatening diseases may need to be registered to ClinicalTrials.gov if they meet other criteria in FDAMA.